Author

Feben Habtehyimer

Observed name: F. Habtehyimer

Institution: Johns Hopkins University

Observed institutions: Johns Hopkins University, Johns Hopkins Medicine, Towson University

ORCID: 0009-0006-2992-0822

Observed ORCID: 0009-0006-2992-0822

OpenAlex ID: A5019367472

Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

2023 · Xianming Zhu, Kelly A Gebo, et al. · The Lancet Microbe · 75

Early antibody treatment, inflammation, and risk of post-COVID conditions

2023 · Kelly A. Gebo, Sonya L. Heath, et al. · mBio · 21

SARS‐CoV ‐2 seroprevalence among blood donors in Uganda: 2019–2022

2023 · Evan M. Bloch, Dorothy Kyeyune, et al. · Transfusion · 14

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients

2023 · Andrew H. Karaba, Jake D. Kim, et al. · American Journal of Transplantation · 12

The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir

2022 · Sarah E. Benner, Yolanda Eby, et al. · JCI Insight · 12

COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial

2023 · Feben Habtehyimer, Xianming Zhu, et al. · Microbiology Spectrum · 10

HIV Superinfection in Kidney Transplant Recipients With HIV Who Received Organs From Donors With HIV

2025 · Gracie M Rozek, Ping Yang, et al. · The Journal of Infectious Diseases · 5

Erratum for Gebo et al., “Early antibody treatment, inflammation, and risk of post-COVID conditions”

2023 · Kelly A. Gebo, Sonya L. Heath, et al. · mBio · 5

Early Treatment, Inflammation and Post-COVID Conditions

2023 · Kelly A. Gebo, Sonya L. Heath, et al. · medRxiv · 4

Mycobacteriophage Alexphander Gene 94 Encodes an Essential dsDNA-Binding Protein during Lytic Infection

2024 · Emmanuel Chong Qui, Feben Habtehyimer, et al. · International Journal of Molecular Sciences · 3

401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody Therapy

2023 · Yuriko Fukuta, Kelly Gebo, et al. · Open Forum Infectious Diseases

OA2‐AM23‐ST‐23 | Early Convalescent Plasma Treatment Reduces Inflammation After Symptomatic COVID‐19

2023 · X. Zhu, F. Habtehyimer, et al. · Transfusion

Works count: 12

Citation count: 161

H-index: 6

I10-index: 6